Cardiovascular Risk Following Conversion to Belatacept from a Calcineurin Inhibitor in Kidney Transplant Recipients: A Randomized Clinical Trial

Obbo W. Bredewold,Joe Chan,My Svensson,Annette Bruchfeld,Johan W. de Fijter,Hans Furuland,Josep M. Grinyo,Anders Hartmann,Hallvard Holdaas,Olof Hellberg,Alan Jardine,Lars Mjornstedt,Karin Skov,Knut T. Smerud,Inga Soveri,Soren S. Sorensen,Anton-Jan van Zonneveld,Bengt Fellstrom

KIDNEY MEDICINE（2023）

Cited 3|Views42

Key words

Kidney transplantation,randomized clinical trial,belatacept,calcineurin inhibitors,tacrolimus,cardiovascular disease,mortality,pulse wave velocity,blood pressure,arterial stiffness

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined